Le Huang

Highly Potent Immunotoxins Targeting the Membrane-distal N-lobe of GPC3 for Immunotherapy of Hepatocellular Carcinoma

Hanjie Li, Yaxi Yang, Qian Wang, 2022, Journal of Cancer.

Generation of TIM3 inhibitory single-domain antibodies to boost the antitumor activity of chimeric antigen receptor T cells

Qian Wang, Xiaoqing Yang, Qian Wang, 2021, Oncology letters.

EGFRvⅢ-targeted immunotoxin combined with temozolomide and bispecific antibody for the eradication of established glioblastoma.

Mingqian Feng, Xiaobing Jiang, Xuan Wang, 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Combination Therapy of Hepatocellular Carcinoma by GPC3-Targeted Bispecific Antibody and Irinotecan is Potent in Suppressing Tumor Growth in Mice

Mitchell Ho, Mingqian Feng, Xinjun Liang, 2021, Molecular Cancer Therapeutics.

Immunotherapy of Epstein-Barr virus (EBV) infection and EBV-associated hematological diseases with gp350/CD89-targeted bispecific antibody.

Yaxi Yang, Mingqian Feng, Xiaoyan Wu, 2023, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Immunotherapy of Epstein-Barr virus (EBV) infection and EBV-associated hematological diseases with gp350/CD89-targeted bispecific antibody.

Yaxi Yang, Mingqian Feng, Xiaoyan Wu, 2023, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.